Weekly Dose #50 - Pause on vaccine trial; Benefits for steroid therapy in COVID patients; Higher doses of diabetes treatment okay'd; First non-hormonal contraceptive; FDA issue SCS warning

<p><span style="font-weight: 400;">We cover AstraZeneca’s decision to pause their COVID-19 vaccine trial; New studies indicate benefits for steroid therapy in COVID patients; Higher doses of diabetes treatment gain approval; The first non-hormonal contraceptive is launched; The FDA issues a letter regarding spinal cord stimulators; And we  wrap up the latest news on drugs in the pipeline.</span></p>